Vivo Capital Closes Oversubscribed $635M Life Sciences Fund

Login to View

Healthcare investment firm Vivo Capital has announced the final closing of its life science fund, Vivo Opportunity Fund, at an oversubscribed US$635 million, bringing the firm’s total funds under management to over US$2.2 billion.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in